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Carbon dioxide removal in acetate hemodialysis: Effects on acid base
balance. Studies were performed in patients on maintenance acetate
hemodialysis to assess the quantity and processes involved in the
removal of carbon dioxide (C02) during the treatment. For this purpose
the CO2 losses from whole blood were evaluated in vivo using a mass
balance technique. The data demonstrated that the CO2 recovered in
the dialysate exceeded the amount calculated to have left the blood in
the same period. This observation suggested that CO2 may be generated
by the blood cells as they go through the dialyzer. In vitro studies
confirmed this observation and established that the uremic blood cells
can generate CO2 when exposed to a low Pco2 and/or HCO3. The net
effect of this CO2 generation may be hydrogen ion gain by the patient.
The contribution of ultrafiltration to the losses of CO2 depends on the
volume of ultrafiltrate and the plasma HCO3 concentration. The dialy-
sance of total CO2 was found to be equal to that of urea nitrogen.
Treatments with high urea dialysance may interfere with the acute and
chronic correction of the acid base balance of these patients. The data
presented suggest that multiple factors related to the removal of CO2
during acetate dialysis may be responsible in part for the low plasma
bicarbonate observed in patients on chronic maintenance hemodialysis.
Epuration du carbonique en hemodialyse avec acetate: Effets sur Ia
balance acido-basique. Des etudes ont été effectuées chez des malades
en hemodialyse périodique avec acetate pour préciser La quantité et les
mécanismes mis enjeu dans l'épuration du carbonique (CO2) pendant le
traitement. Pour cela, les pertes en CO2 du sang total ont été évaluées
in-vivo en utilisant une technique de balance massique. Les données
ont démontré que le CO2 récuperé dans le dialysat depassait Ia quantite
calculée ayant quitté Ic sang pendant Ia même période. Cette observa-
tion a suggéré que du CO2 pourrait étre généré par les cellules sanguines
lorsqu'elles passent a travers le dialyseur. Les etudes in-vitro ont
confirmé cette observation et ont établi que les cellules sanguines
urémiques peuvent genérer du CO2 lorsqu'elles sont exposées a une
faible Pco2 ou/et HCO3. L'effet net de cette generation de CO2 pourrait
être un gain d'ions hydrogenes par le malade. La contribution de l'ultra-
filtration aux pertes de CO2 depend du volume d'ultrafiltrat et de Ia
concentration plasmatique d'HCO3. La dialysance du CO2 total a été
trouvée égale a celle de l'azote uréique. Des traitements avec une forte
dialysance de l'urée pourraient interferer avec Ia correction aiguC et
chronique de Ia balance acido-basique chez ces malades. Les données
présentées suggèrent que de multiples facteurs relies a l'épuration du
CO2 pendant Ia dialyse avec acetate pourraient Ctre responsables en
partie des faibles bicarbonates plasmatiques observées chez les malades
en hémodialyse periodique chronique.
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Dietary intake and metabolism provide a number of potential
sources of acid. Sulfur in the sulfur-containing amino acids is
oxidized to sulfuric acid, phosphorus in proteins and phospho-
lipids is converted to phosphoric acid, and organic acids may be
produced in excess of the capacity to metabolize them. Since
none of these products can exist in the body fluids as the free
undissociated acid, the hydrogen must react with the buffers of
the body. Most of the extracellular buffering occurs by reaction
of the acid with bicarbonate to yield the corresponding sodium
salt and carbonic acid. The carbonic acid is then converted to
water and carbon dioxide, the latter being excreted in the lungs.
The net result is the replacement in the extracellular fluid of one
eqivalent of bicarbonate by one anion equivalent of the acid [1].
The buffer capacity of the extracellular fluid can be restored if
bicarbonate is regenerated. In health this is accomplished by
the kidney. In patients with chronic renal failure on mainte-
nance dialysis bicarbonate regeneration must be achieved by
the treatment technique.
In estimating the contribution of acetate hemodialysis to the
acid base balance of these patients, it is useful to calculate the
net base given during the treatment, that is, the sum of acetate
administered minus the bicarbonate loss from the blood to the
dialysate. Organic anions wasted during the treatment must be
considered base equivalent and, therefore, added to the bicar-
bonate loss [2]. As acetate uptake and metabolism are quantita-
tively related to the generation of bicarbonate, the net base
retained during the treatment is analogous to bicarbonate
regeneration. To maintain body buffers, the bicarbonate dissi-
pated by the hydrogen ions produced during the interdialytic
period must be completely replaced during the treatment.
It has been calculated that the net base given during acetate
hemodialysis is sufficient to regenerate the extracellular bicar-
bonate [3, 4]. In the absence of base supplement a persistently
low plasma bicarbonate, however, is a common finding in these
patients [5, 6). These two observations are difficult to reconcile.
It is of critical importance in the computation of the net base
given in acetate hemodialysis to assess the quantity of bicarbon-
ate removed. Earlier studies have estimated bicarbonate loss by
calculating the bicarbonate concentration in plasma and dialy-
sate fluid [7—101. The use of plasma concentration neglects, or
at best indirectly estimates, the contribution of blood cells. In
the dialysate fluid, the low concentration of bicarbonate makes
its determination technically difficult. The difficulty in measur-
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ing the high flow rates of blood and dialysate compound the
uncertainty of the quantity of bicarbonate removed throughout
the treatment.
The objective of this paper is to re-examine the quantity as
well as the processes involved in the removal of bicarbonate
from the patient's blood in acetate hemodialysis. For this
purpose, we have utilized a different approach compared to
previous studies [7—10]. In our studies, we measured the total
CO2 content in whole blood and dialysate. We feel this method-
ology permitted a more accurate assessment of the removal of
bicarbonate in this treatment modality. The passage of blood
through the dialyzer results not only in the loss of bicarbonate
but also in a redistribution of the different forms in which
carbon dioxide is transported within the blood. Carbon dioxide
(C02) is present in whole blood (plasma and blood cells) as
dissolved C02, H2C03, HCO3, and carbamino CO2. In the
dialysate, carbon dioxide is present as dissolved C02, H2C03,
and HCO3. The direct measurement of CO2 was performed by
the use of a gas extraction technique and expressed as CO2
content or total CO2 (TCO2) in milliequivalents per liter. This
method measures the sum of the different forms of CO2 in whole
blood and dialysate and avoids inferential calculations. To
minimize technical errors in the flow measurements, we used,
as an independent variable, the mass balance of urea nitrogen.
Only experiments with a closed urea nitrogen mass balance
were simultaneously analyzed for CO2 removal.
The following parameters were studied: (1) carbon dioxide
losses from whole blood during acetate dialysis; (2) contribution
of ultrafiltration to the CO2 losses during the treatment and, (3)
efficiency of the treatment and its effects on CO2 removal.
Methods
In vivo experiments. Studies were performed in patients
undergoing maintenance hemodialysis. A 1.5 m2 hollow fiber
dialyzer (Travenol HF 1500, Travenol Laboratories, Inc., Mor-
ton Grove, Illinois) or a 1.2 m2 parallel plate dialyzer (Gambro
17, Gambro AB, Lund, Sweden) was used. A standard dialysate
with an acetate concentration of 38.0 mEq/liter and glucose of
200.0 mg/dl was used. Samples were obtained from the blood
entering (inlet) and leaving the dialyzer (outlet) at the beginning
and at the end of 5-mm collecting periods. A mean value
derived from the initial and final blood samples of each collec-
tion period was utilized in the calculations. The corresponding
dialysate was collected in a sealed container, analyzed in
triplicate, and a mean value was obtained.
Measurements and calculations. Inlet blood flow was mea-
sured by the bubble time method utilizing a race track of 50 cm
after the blood pump [10]. Outlet blood flow, lower than the
inlet due to ultrafiltration, was calculated from Eq. 1. Please
refer to the Appendix for a complete listing of abbreviations
used in the text.
QB1 x Hct1QB0 ml/min =
Hct0
The ultrafiltration rate was calculated from the changes in
blood flow as shown in Eq. 2.
Qu mI/mm = QB1 — QB0 (2)
Dialysate outlet flow was measured by volumetric timed
collections. Dialysate inlet flow was calculated using Eq. 3.
QD1 ml/min = QD0 + Quf (3)
Plasma pH and Pco2 were measured with blood gas analyzer
(Radiometer Mark II, Radiometer AS, Copenhagen, Denmark).
Plasma bicarbonate and plasma total CO2 content were calcu-
lated using the Henderson-Hasselbalch equation [11]. Total
CO2 content in whole blood (plasma and blood cells) was
measured by the gas extraction technique using a microgaso-
meter (Natelson, Scientific Industries Inc., Springfield, Massa-
chusetts) or a magnematic blood gas apparatus (Thomas-Van
Slyke, A. H. Thomas Co., Philadelphia, Pennsylvania) [12].
Standards of 1, 3, 5, 10, 20 mEq/liter of CO2 were utilized to test
the accuracy of the measurements. Urea nitrogen in plasma and
dialysate was determined with an automated method [13].
Whole BUN concentration was calculated utilizing a red cell
partition coefficient (K) of 0.86 [14] as follows:
BUN mglml = [(1 — Hct) + (K X Hct)] x PUN (4)
The coefficient of variation for the methods used in these
experiments were: Blood flow rate 4.5%, plasma TCO2 2.0%,
whole blood TCO2 1.5%, hematocrit 1.1%, and plasma urea
nitrogen 2.0%.
To assess technical error in analysis and flow, we computed
urea nitrogen mass balance in all collections as shown in Eq. 5.
QB, x BUN1 mg/mm = (QBO x BUNQ)
+ (QDO X DUNO) (5)
The mass balance error (MBE) was appraised accordingly by
Eq. 6 [15]. Only collections with a urea nitrogen MBE of less
than 5% were accepted for further analysis [15].
MBE% = 200
(QB1 x BUN1 — QB0 x BUN0) — (QDO x DUNO) 6(QB1 x BUN1 + QB0 x BUN0) + (QDO x DUNO)
The amount of CO2 entering the dialyzer was calculated from
Eq. 7 and the amount leaving the dialyzer from Eq. 8.
CO2 entering the dialyzer = (QB1 x TCO2 B1)
+ (QD1 x TCO2 Di)
CO2 leaving the dialyzer = (QBO X TCO2 B0)
+ (QDO X TCO2 Do)
(7)
(8)
To determine the origin of the CO2 recovered in the dialysate,
we used Eqs. 9 to 13 that follow:
CO2 lost from blood mEq/min = (QB1 X TCO2 B)
— (QBO x TCO2 B0)
(1) CO2 lost from plasma mEq/min = (QP1 x TCO2 P1)
— (QPO x TCO2 P0)
CO2 lost from RBC mEq/min = CO2 lost from blood
— CO2 lost from plasma
CO2 added to the dialysate mEq/min
= (QDO x TCO2 D0) — (QD1 x TCO2 Di)
(9)
(10)
(11)
(12)
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Table 1. Urea nitrogen mass balance, total urea nitrogen in = total urea nitrogen out (mean sEM)0
QB, mi/mm x BUN ng/ml = QB0 mi/mm X BUN0 mg/mi + QD0 mi/mm X DUN0 mg/mi
(Blood in, mg/mm) (Blood out, mg/mm) (Dialysate out, mg/mm)
290.6 12.1 x 0.500 0.035 = 282.2 12.4 x 0.223 0.016 + 554.6 10.3 x 0.148 0.011
147.8 11.6 mg/mm 146.2 11.8 mg/mm
In vitro studies. For these experiments blood samples were
(13) obtained from normal volunteers and patients on maintenance
hemodialysis. The samples were drawn from a peripheral vein
in the volunteers and from the arterial line, during the course of
treatment, in the patients. The blood was diluted with a C02-
free dialysate in a 1:1 ratio. A 12-mi blood sample was obtained
in heparin-rinsed syringes and then transferred to a beaker kept
on ice. An oil seal was used. Two milliliters of blood were then
removed for measurements (predilution sample). Thereafter, 10
ml of standard glucose containing dialysate was added to the
beaker, mixed and after 5 mm a new specimen was obtained
(postdilution sample). The following measurements were car-
ried out as described in the in vivo experiments: plasma pH,
Pco2, and TCO2, and whole blood TCO2. The dialysate compo-
sition used for the dilution was: glucose 200 mg/dl, acetate 41
mEq/liter, sodium 140 mEq/liter, chloride 106 mEq/liter, mag-
nesium 1.5 mEq/liter, potassium 2.0 mEq/liter, and calcium 3.5
mEq/liter. TCO2 was not measurable.
(14) Blood cell experiments. In these experiments the blood
samples were obtained as above. Blood was centrifuged and the
plasma was discarded to achieve a sample with a 97 2.0%
fJ5 hematocrit. The Van Slyke apparatus was used to measureTCO2 with (in the predilution sample) 0.5 ml of blood cells, 3.0
Abbreviations are in the Appendix.
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mass balance during acetate hemodialysis
0 in 22 collections. The asterisk represents
P <0.001.
CO2 generation mEq/min = CO2 leaving — CO2
entering the dialyzer
Ultrafiltration studies. To determine the effect of plasma
TCO2 concentration and volume of ultrafiltrate on CO2 losses,
patients with a broad range of plasma bicarbonate concentra-
tions were studied with variable volumes of ultrafiltrate. The
inlet of the dialyzer was occluded and the outlet was connected
to a vacuum source. A transmembrane pressure of 500 to 600
mm Hg was maintained by adjusting the negative pressure
generated by the vacuum source. The ultrafiltrate was collected
in a graduated reservoir [161. Blood samples were obtained at
the inlet and analyzed for plasma TCO2 concentration. The
volume and TCO2 concentration of the ultrafiltrate was also
obtained.
Dialysance studies. Urea nitrogen and CO2 dialysance were
calculated from Eqs. 14 to 15.
- QD0 x DUN0DialuN —
BUN,
- (QDO X DTCO20) — (QD1 x DTCO2I)Dialco —
2 BTCO2, — DTCO2,
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Table 2. CO2 mass balance, total CO2 in = total CO2 out (mean SEM)a
QB1 mI/mm x BTCOZ mEq/liter = QB0 mi/mm x BTCO2O mEq/liter + QD0 mI/mm x DTCO mEq/liter — QD1 mI/mm x DTCO2. mEq/liter
(Blood out, mEq/min) (Dialysate out , mEqimin) (Dialysate in, mEq/min)
290.6 12.1 x 20.3 0.3 = 282.2 12.4 x 10.4 0.4 + 554.6 10.3 x 6.24 0.22 — 546.7 11.0 x 0.20 0.02
5.94 0.31 mEq/min = 6.40 0.33 mEq/mmn
a P < 0.02.
ml of sulfuric acid (0.66 N), and 0.5 ml of sodium hydroxide (5
N) to 0.5 ml of blood cells from the same sample. Dilution was
then produced by adding 0.5 ml of dialysate into the instrument.
After 2 mm, 3.0 ml of sulfuric acid (0.66 N), and 0.5 ml of
sodium hydroxide (5 N) were added as before. The results of the
in vitro studies have been expressed as 20 ml for the predilution
and 40 ml for the postdilution specimen.
Statistical analysis. All data are expressed as the mean
SEM. Significance between means was calculated using the
Student paired t test.
The difference in CO2 entering and leaving the dialyzer (A
C02) was calculated for each of the 22 collections. The average
change (A) was tested for significance from a zero change by
Student's t test for paired observations using a P value of less
than 0.05 level for statistical significance.
Results
CO2 mass balance in acetate hemodialysis. The urea nitrogen
mass balance was assessed in more than 45 experiments, but
only 22 collections in ten patients met the criteria of a mass
balance error of less than 5%. The overall values for urea
nitrogen mass balance for these 22 experiments are shown in
Table 1. The individual values are depicted in Figure 1. The
simultaneously calculated CO2 mass balance is shown in Table
2. In Figure 1 and Table 3 are depicted values from the
individual studies. The ultrafiltration rate averaged 8.4 1.4
mI/mm (range, 0.0 to 24.0 mI/mm). Plasma TCO2 was calculated
from the measured plasma pH and plasma CO2 tension (mm
Hg). In whole blood, TCO2 was measured directly, representing
the sum of TCO2 in the plasma and the blood cells. According-
ly, from the whole blood and the plasma TCO2, the blood cell
TCO2 content can be derived. In 1 mm an average of 290.6 ml of
blood entered the dialyzer and 282.2 ml returned to the patient.
The plasma at the inlet contained a total of 4.64 0.25 mEq of
CO2. At the outlet, the plasma contained a total of 2.49 0.18
mEq of CO2. The difference between these values, 2.15 0.11
mEq is the amount of CO2 lost from the plasma to the dialysate.
The 78.7 ml of blood cells carried 1.26 0.12 mEq of CO2 at the
inlet and 0.44 0.07 mEq when returning to the patient.
Therefore, 0.82 mEq of CO2 was lost from the blood cells
during their passage through the dialyzer (Table 4). While the
plasma and blood cells lost CO2 in their transit through the
dialyzer, the dialysate fluid gained CO2. At the dialysate inlet
total CO2 content and partial pressure of CO2 were extremely
low. In the dialysate outlet TCO2 and Pco2 averaged 6.24
0.22 mEq/liter and 12.6 1.0 mm Hg, respectively.
The total amount of CO2 entering the dialyzer, in blood and
dialysate, averaged 5.94 0.31 mEq/min. The CO2 leaving the
dialyzer, that is, the sum of CO2 in the blood outlet (2.95 0.20
mEq/min) and the amount added to the dialysate (3.33 0.13
mEq/min), averaged 6.30 0.33 mEq/min. This quantity of CO2
leaving the device was significantly greater than the amount
entering it. The average excess of CO2 was 0.36 0.09
mEq/min (P < 0.001) (Table 4).
In vitro studies. Table 5 represents the results of the blood
dilution experiments. The dilution of normal blood with CO2-
free dialysate resulted in a fall in hematocrit and TCO2, not
statistically different from the 50% reduction expected from
such a dilution. In the uremic blood, the hematocrit also fell as
anticipated, whereas TCO2 decreased significantly less than the
50% expected. The predilution plasma pH in the uremic blood
was higher than the normal blood as a consequence of the
dialysis treatment. The data in Figure 2 depicts the total amount
of CO2 present in the 20 ml of blood before dilution and in the 40
ml of diluted blood for the normal and uremic samples. In the
normal blood the total quantity of CO2 averaged 0.490 0.020
mEq. After the dilution with the C02-free dialysate, the total
amount of CO2 in the sample was not significantly different and
averaged 0.500 0.010 mEq. The dilution of the uremic blood,
on the other hand, resulted in a significant increase in the
quantity of CO2 from 0.390 0.010 to 0.420 0.010 mEq (Fig.
2). To confirm this observation and avoid the difference in
hematocrit between normal and uremic blood, similar experi-
ments were done using normal and uremic blood cells (Hct 97.0
2.0%). Comparable results to those obtained in the whole
blood experiments were observed (Fig. 3).
Ultrafiltration and CO2 removal. The loss of carbon dioxide
from blood to dialysate in acetate hemodialysis occurs not only
by diffusion but also by convection due to ultrafiltration. Table
6 demonstrates that the amount of CO2 loss due to ultrafiltration
depends on the volume of ultrafiltrate and TCO2 plasma
concentration.
Dialysis efficiency and CO2 removal. Blood dialysance of
urea nitrogen and TCO2 were measured simultaneously. A wide
range of blood flows (100 to 420 ml/min) were used (Fig. 4). The
results demonstrated that no significant differences existed
between these dialysances. Accordingly, the removal of CO2
will increase proportionately with the increase in urea nitrogen
removal.
Discussion
As previously stated, the objective of this paper was to study
the quantity as well as the processes involved in the transfer of
CO2 from blood to dialysate during the passage of blood
through the dialyzer and to assess the effect of CO2 removal on
the acid base balance of patients on maintenance acetate
hemodialysis.
The CO2 losses during dialysis were evaluated by comparing
the amount of CO2 entering the dialyzer (blood and dialysate
inlet). In these calculations potential sources of error stem from
the technical difficulties in measuring the CO2 concentration
and the blood and dialysate flow rates. The CO2 concentration
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TabIc 3. Blood and dialysate values for 22 collections
Blood
Patient
no. Inlet
QB
mi/mm
Outlet Inlet
Hct
%
Outlet Inlet
Q
mi/mm
Outlet Inlet
pH
Outlet Inlet
Pco2
mmHg
Outlet
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
225
250
241
242
265
241
281
270
260
350
308
310
300
410
420
370
350
270
300
240
240
250
215
240
231
232
265
241
281
260
250
340
300
300
300
400
410
370
350
263
276
231
222
232
25.7
20.0
23.8
20.9
27.0
27.5
28.0
29.0
30.0
36.0
37.0
37.0
30.0
19.0
20.0
24.0
25.0
36.0
23.0
27.0
27.0
26.0
26.9
20.8
24.9
21.9
27.0
27.5
28.0
30.0
31.2
37.0
38.0
38.2
30.0
19.5
20.5
24.0
25.0
37.0
25.0
28.0
29.0
28.0
167.2
200.0
183.6
191.6
193.5
174.7
202.3
191.7
182.0
224.0
194.0
195.3
210.0
332.1
336.0
281.2
262.5
172.8
231.0
175.2
175.2
185.0
155.4
192.0
183.7
183.3
193.5
175.9
202.3
181.7
172.0
214.0
186.0
185.3
210.0
321.1
326.0
281.2
262.5
165.7
207.0
166.2
157.2
167.0
7.400
7.510
7.610
7.600
7.530
7.540
7.580
7.380
7.350
7.380
7.370
7.390
7.310
7.340
7.380
7.350
7.360
7.378
7.475
7.490
7.450
7.370
7.350
7.810
7.600
7.720
7.690
7.650
7.650
7.350
7.340
7.350
7.350
7.360
7.350
7.310
7.320
7.290
7.320
7.390
7.420
7.470
7.400
7.380
36.3
23.3
20.8
21.5
25.5
24.5
21.5
37.5
44.0
35.0
35.0
35.0
40.0
40.0
41.0
33.0
35.0
35.5
36.8
32.0
34.0
42.0
22.4
5.8
9.5
8.8
9.3
8.5
8.5
21.0
22.0
17.0
22.5
21.0
21.0
28.0
28.0
23.0
23.0
21.3
22.5
20.0
24.0
26.0
Mean
so
SEM
290.6
55.5
12.1
282.2
56.8
12.4
27.2
5.3
1.2
28.1
5.4
0.2
211.9
47.5
10.5
204.1
48.2
10.5
7.434
0.090
0.020
7.449
0.154
0.033
33.2
7.0
1.5
18.8
6.8
1.5
mEq/min %
Plasma 2.15 0.13 62.2
Red blood cells 0.82 0.11 24.0
Dialysate inlet 0.11 0.01 3.2
Generated 0.36 0.09 10.4
Total CO2 out 3.46 0.13
in these experiments was measured in whole blood and dialy-
sate using a well established and accurate technique that
includes all the different forms in which CO2 is transported in
plasma, blood cells, and dialysate [12]. Blood and dialysate
flows at the inlet and outlet were measured or calculated
separately. To further evaluate these determinations the tech-
nique of urea nitrogen mass balance was used. This parameter
depends critically on an accurate estimation of blood and
dialysate flow rates. A low urea nitrogen mass balance error of
less than 5% provides a strong support for the measured and
calculated flows [15].
When the quantities of CO2 entering and leaving the dialyzer
were compared, they were found to be significantly different (P
<0.001) (Fig. 1). An average of 0.36 0.09 mEq/min of CO2
was demonstrated in excess of the amount which entered (Table
4), which indicates that CO2 is generated and lost to the
dialysate during the passage of blood through the dialyzer.
In vitro studies were performed to confirm these observa-
tions. A fall in Pco2 and TCO2 concentration similar to that
Hct
Plasma
Pco2
Blood
TCO2
(%) Plasma pH (mm Hg) (mEq/lifer)
Uremic blood
(N = 14)
Before dilution
After dilution
26,5 1.2 7.46 0.02 31.7 1.7 19.4 0.6
13.3 0.6 7.47 0.02 16.0 0.8 10.6 0.3a
a p < 0.05 different from 50% reduction expected from dilution.
occurring between blood entering and leaving the dialyzer was
developed (Table 5). A significant generation of CO2 was
demonstrated when the uremic whole blood (Fig. 2) or blood
cells (Fig. 3) were diluted with CO2-free dialysate. Thus, the in
vitro studies confirm the observation made in the in vivo
studies. Uremic whole blood and uremic blood cells can gener-
ate significant amounts of CO2 when exposed to conditions
comparable to those found in acetate hemodialysis.
The in vitro CO2 generation demonstrated in the uremic
blood averaged 0.3 x l0- mEq/min/ml of blood (CO2 =0.03
mEq in 20 ml of blood; incubation period 5 mm). This rate of
CO2 generation is considerably higher than the one measured in
quiescent normal red cells [17]. The capacity of the normal
erythrocytes to increase CO2 generation when stimulated,
Table 4. Source of total CO2 recovered in the dialysate outlet
(mean 5EM)
Table 5. Effects of blood dilution in vitro
Normal blood
(N =8)
Before dilution
After dilution
45.0 1.1 7.42 0.01 44.8 1.2 24.2 0.8
23.0 0.8 7.38 0.03 23.3 0.9 12.5 0.6
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TabIe 3. (Continued)
Blood Dialysate
PTCO2 BTCO Qo DTCO
mEqiliter mEqiliter mI/mm DpH mEqiliter
Inlet Outlet Inlet Outlet Inlet Outlet Inlet Outlet Inlet Outlet
22.9 12.6 18.2 9.0 525 535 7.000 7.580 0.20 5.2
18.7 8.9 18.5 8.8 530 540 6.900 7.500 0.19 5.0
20.9 9.5 20.0 9.8 520 530 6.900 7.590 0.18 5.3
21.1 11.1 19.7 10.8 510 520 7.100 7.470 0.20 5.3
21.4 11.2 19.5 8.5 630 630 7.000 7.520 0.20 5.2
21.0 9.5 19.0 8.0 630 630 7.200 7.460 0.20 5.2
20.2 9.5 19.4 7.4 700 700 7.000 7.530 0.17 5.4
22.6 11.8 20.9 10.7 490 500 6.900 7.240 0.20 6.8
24.7 12.1 21.6 10.9 490 500 6.900 7.310 0.20 6.8
21.1 9.6 19.8 9.0 550 560 7.000 7.370 0.20 6.5
20.6 12.6 17.9 10.4 550 560 7.100 7.380 0.20 6.5
21.5 12.1 20.7 8.5 535 543 7.100 7.340 0.20 7.1
20.7 11.8 21.2 9.2 533 543 7.000 7.320 0.20 7.3
22.1 14.5 22.1 12.9 565 565 6.900 7.280 0.18 8.7
24.7 14.8 24.1 13.1 555 565 7.000 7.300 0.20 8.7
18.6 11.4 19.3 10.3 530 540 6.700 7.500 0.20 5.9
19.3 12.1 19.8 10.8 540 540 7.100 7.220 0.20 5.9
21.3 13.2 19.7 10.6 533 540 7.200 7.110 0.20 5.2
27.3 14.8 22.9 13.0 596 600 7.000 7.280 0.18 6.6
24.5 14.8 22.0 12.6 511 520 7.000 7.220 0.20 6.3
23.9 15.0 20.3 12.7 502 520 7.000 7.260 0.20 6.8
24.7 15.8 20.4 11.5 502 520 7.000 7.190 0.20 5.5
21.9 12.2 20.3 10.4 546.7 554.5 7.000 7.362 0.20 6.24
2.2 2.0 1.5 1.7 50.3 46.6 0.109 0.133 0.01 1.05
0.5 0.2 0.3 0.4 11.0 10.2 0.024 0.029 0.02 0.22
Fig. 2. In vitro experiments in normal and uremic blood. TCO2
content is shown before and after dilution.
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Fig. 3. In vitro experiments in normal and uremic blood cells. TCO2
content is shown before and after dilution.
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however, is quite large. The addition of methylene blue, for
example, can increase the rate of CO2 production in normal red
cells 3000 times [17]. The erythrocytes from uremic subjects are
metabolically different from normal red cells [19—221. The
activity of several enzymes in the red cell have been reported to
be elevated in chronic renal failure [191. The activity of glucose-
6-phosphate dehydrogenase (G-6-PD), for instance, is several
fold higher in uremic patients than in a normal control group
[22]. It is likely, therefore, that intrinsic red cell differences may
be important in explaining the variance in CO2 generation
observed between normal and uremic blood (Figs. 2 and 3).
The studies performed during hemodialysis demonstrated a
CO2 generation of 1.2 x I0 mEq!min/ml of blood going
through the dialyzer (XCO2 = 0.36 mEq/min; QB = 290.6
mI/mm). The higher CO2 generation observed in vivo as com-
pared to in vitro may be explained by important experimental
differences. The in vivo studies were performed at a higher
temperature, a factor which has been shown to stimulate CO2
production in red blood cells [17]. White blood cells may play a
greater role in vivo than in the in vitro studies. Leukocytes are
trapped in a large number on the membranes of the dialyzer
during the treatment [24]. Since the normal white cells have a
glycolytic activity at least 100 times greater than the erythro-
cytes [23], the membrane-trapped cells may contribute to the
observed CO2 generation during the treatment. Finally, the in
vitro studies do not reproduce the dynamic events that occur
during hemodialysis. As the blood goes through the dialyzer,
dissolved CO2 and bicarbonate ions diffuse rapidly across the
dialyzer membrane from plasma to dialysate. As a conse-
quence, a gradient may develop between blood cells and plasma
resulting in the diffusion of carbon dioxide and bicarbonate out
of the cells. Carbon dioxide may diffuse more rapidly than the
bicarbonate ions and the intracellular pH may rise. Such a
change in intracellular pH may stimulate the metabolism of the
cellular elements of the blood. It has been reported that a rise in
intracellular pH promptly stimulates the pentose-monophos-
phate pathway in red blood cells [17]. This reaction requires
glucose as a substrate and yields one carbon dioxide and one
pentose molecule and two hydrogen ions [181. The accelerated
metabolism of glucose to pentose and CO2 by cells in their
passage through the dialyzer may explain the observation of
more CO2 leaving than entering the device. The outcome of this
CO2 generation may be an increased hydrogen load in the blood
cells returning to the patient. This process is clearly not life-
threatening, and further studies are necessary to define the
quantitative impact, if any, of this phenomena in the acid base
homeostasis of these patients.
The CO2 recovered in the dialysate is lost from the blood to
the dialysate by diffusion and to a lesser extent by ultrafiltra-
tion. Our studies showed that the amount of CO2 lost in the
ultrafiltrate was considerable and varied directly with the
volume of ultrafiltrate and the plasma TCO2 concentration
(Table 6). It has been suggested from in vitro studies that
increasing the rate of ultrafiltration decreases acetate dialy-
sance [4]. Ultrafiltration during hemodialysis, therefore, dimin-
ishes net base given both by increasing the removal of CO2 and
by decreasing the quantity of acetate delivered.
The dialysance of CO2 and urea nitrogen are identical (Fig.
4). This observation indicates that, if the efficiency of the
treatment is defined by urea nitrogen removal, the more effi-
cient the treatment the greater the amount of CO2 removal.
Several investigators have demonstrated that patients on ace-
tate hemodialysis can metabolize only a limited amount of
acetate per minute [25, 26]. The highest urea nitrogen dialy-
sance that can be achieved without deleterious effects during
acetate hemodialysis may be determined by the CO2 removal. If
during the treatment the hydrogen gain (CO2 removal plus
hydrogen generation) exceeds the capacity to metabolize the
administered acetate, plasma bicarbonate will fall and plasma
acetate will increase [27]. A higher plasma acetate concentra-
tion will impair acetate gain by the blood because the gradient
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Table 6. Isolated ultrafiltration effect of CO2, concentration and
volume of ultrafiltrate in CO2 losses (N = 7)
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from bath to plasma is diminished. The net base given during
the treatment will be less. The net effect of high efficiency
dialysis may then be acidosis and less net base given during the
treatment.
Summary, In acetate hemodialysis several factors may impair
the acquisition of sufficient net base to reconstitute the body
buffers: (1) ultrafiltration, (2) the efficiency of the treatment,
and (3) hydrogen ion generation during the treatment. It is likely
that a combination of these factors may help to explain the
persistently low plasma bicarbonate almost universally ob-
served in patients on maintenance acetate hemodialysis.
Appendix
The following abbreviations are used throughout the text: Q,
flow rate (mi/mm); B,, blood inlet: B0, blood outlet; P1. plasma
inlet; P0, plasma outlet; D, dialysate inlet; DB0, dialysate
outlet; ultrafiltration rate (mI/mm); Hct1, hematocrit inlet
(%); Hct0, hematocrit outlet (%); RCM, red cell mass (mi/mm);
PUN, urea nitrogen in plasma (mg/mi); BUN, urea nitrogen in
blood (mg/mI); DUN, urea nitrogen in dialysate (mg/mi); TCO2,
total CO2 content (mEq/liter); DialuN, urea nitrogen dialysance
(mI/mm); Dialco,, CO2 dialysance (mI/mm).
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